Featured Research

from universities, journals, and other organizations

Do elite 'power sport' athletes have a genetic advantage?

Date:
September 25, 2013
Source:
Wolters Kluwer Health: Lippincott Williams & Wilkins
Summary:
A specific gene variant is more frequent among elite athletes in power sports, reports a new study.

Power athletes were three times more likely to have the CC genotype compared to endurance athletes, and twice as likely compared to nonathletes.
Credit: Mat Hayward / Fotolia

A specific gene variant is more frequent among elite athletes in power sports, reports a study in the October issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association (NSCA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

A "functional polymorphism" of the angiotensiogen (AGT) gene is two to three times more common in elite power athletes, compared to nonathletes or even elite endurance athletes, according to the new research by Paweł Cięszczyk, PhD, of University of Szczecin, Poland, and colleagues. They write, "[T]he M23T variant in the AGT may be one of the genetic markers to investigate when an assessment of predisposition to power sports is made."

Gene Variant More Common in Elite Power Athletes

The researchers analyzed DNA samples from two groups of elite Polish athletes: 100 power-oriented athletes, from sports such as power-lifting, short-distance runners, and jumpers; and 123 endurance athletes, such as long-distance runners and swimmers and rowers. All athletes competed at the international level -- eg, World and European Championships, World Cups, or Olympic Games. A group of 344 nonathletes were studied for comparison.

The analysis focused on the genotype of the M235T polymorphism of the gene AGT. "Polymorphisms" are genes that can appear in two different forms (alleles). A previous study found that the "C" allele of the AGT gene (as opposed to the "T" allele) was more frequent among elite athletes in power sports.

The genetic tests found that elite power athletes were more likely to have two copies of the C allele -- in other words, they inherited the C allele from both parents. This "CC" genotype was found 40 percent of the power athletes, compared to 13 percent of endurance athletes and 18 percent of nonathletes.

Power athletes were three times more likely to have the CC genotype compared to endurance athletes, and twice as likely compared to nonathletes. At least one copy of the C allele was present in 55.5 percent of power athletes, compared to about 40 percent of endurance athletes and nonathletes.

But Functional Significance Not Yet Clear

In a further analysis, the researchers found no differences in genotype between "top-elite" athletes who had won medals in international-level competition, compared to elite-level athletes who were not medalists.

The new study is the first to replicate previous, independent research showing an increased rate of the CC genotype of the AGT gene among power athletes on Spanish national teams. That study also found about a 40 percent prevalence of the CC genotype among elite power athletes.

The AGT gene is part of the renin-angiotensin system, which plays essential roles in regulating blood pressure, body salt, and fluid balance. There are several possible ways in which the CC genotype might predispose to improved power and strength capacity -- including increased production of angiotensin II, which is crucial for muscle performance. However, the researchers emphasize that the "functional consequences" of the M235T polymorphism remain to be determined.

The study contributes to the rapidly evolving body of research on genetic factors related to exercise, fitness, and performance -- which may one day have implications for identification and training of potential elite-level athletes. Dr Cięszczyk and coauthors conclude, "Identifying genetic characteristics related to athletic excellence or individual predisposition to types of sports with different demands (power or endurance oriented) or even sport specialty may be decisive in recognizing athletic talent and probably will allow for greater specificity in steering of sports training programs."


Story Source:

The above story is based on materials provided by Wolters Kluwer Health: Lippincott Williams & Wilkins. Note: Materials may be edited for content and length.


Journal Reference:

  1. Aleksandra Zarębska, Stanisław Sawczyn, Mariusz Kaczmarczyk, Krzysztof Ficek, Agnieszka Maciejewska-Karłowska, Marek Sawczuk, Agata LeoŃska-Duniec, Jerzy Eider, Agata Grenda, Paweł Cięszczyk. Association of rs699 (M235T) Polymorphism in the AGT Gene With Power but Not Endurance Athlete Status. Journal of Strength and Conditioning Research, 2013; 27 (10): 2898 DOI: 10.1519/JSC.0b013e31828155b5

Cite This Page:

Wolters Kluwer Health: Lippincott Williams & Wilkins. "Do elite 'power sport' athletes have a genetic advantage?." ScienceDaily. ScienceDaily, 25 September 2013. <www.sciencedaily.com/releases/2013/09/130925112343.htm>.
Wolters Kluwer Health: Lippincott Williams & Wilkins. (2013, September 25). Do elite 'power sport' athletes have a genetic advantage?. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130925112343.htm
Wolters Kluwer Health: Lippincott Williams & Wilkins. "Do elite 'power sport' athletes have a genetic advantage?." ScienceDaily. www.sciencedaily.com/releases/2013/09/130925112343.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins